STERIS appoints Pierre Boulud to board; Richard Breeden to retire at 2026 AGM

STERIS plc

Richard C. Breeden notified he will not stand for reelection at 2026 AGM; retirement not due to any disagreement.
Board increased from 9 to 10 members; Pierre Boulud appointed director effective May 5, 2026.
Boulud is CEO of bioMérieux (in vitro diagnostics); previously COO at bioMérieux and exec at Ipsen.
Boulud receives prorated fee of $76,989 in restricted stock units for remainder of board term.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Richard C. Breeden

Director

STE · STERIS plc

Filed: May 7, 2026, 7:59 PM ET

On May 1, 2026, Richard C. Breeden notified STERIS plc (the “Company”) that he will not stand for reelection to the Board of Directors (the “Board”) at the Company’s 2026 Annual General Meeting of Shareholders.

Appointed

Pierre Boulud

Director

STE · STERIS plc

Effective: 2026-05-05
Filed: May 7, 2026, 7:59 PM ET

On May 5, 2026, the Board of the Company increased its size from nine to ten members and appointed Pierre Boulud to serve as a director effective as of that date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Richard C. Breeden departed as Director at STERIS plc.

Action: not stand for reelection
Role: Director

Exact text from the filing

On May 1, 2026, Richard C. Breeden notified STERIS plc (the “Company”) that he will not stand for reelection to the Board of Directors (the “Board”) at the Company’s 2026 Annual General Meeting of Shareholders.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Pierre Boulud was appointed as Director at STERIS plc.

Action: appointed
Role: Director

Exact text from the filing

On May 5, 2026, the Board of the Company increased its size from nine to ten members and appointed Pierre Boulud to serve as a director effective as of that date.

View on SEC.gov

STERIS plc filing history →

Source: SEC EDGAR

accession 0001193125-26-212159

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.